Pandemic impact on aneurysmal subarachnoid hemorrhage in Peru's high COVID-19 lethality setting: A public institutional experience.

Autor:	Flores-Sanchez JD; Department of Neurosurgery, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru., Perez-Chadid DA; Faculty of Medicine, Universidad CES, Medellin, Colombia., Vargas-Urbina J; Department of Neurosurgery, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru., Zumaeta J; Department of Neurosurgery, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru., Rodriguez RR; Department of Neurosurgery, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru., Palacios F; Department of Neurosurgery, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru., Flores-Castillo J; Department of Neurosurgery, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru.
Jazyk:	angličtina
Zdroj:	Surgical neurology international [Surg Neurol Int] 2023 Dec 22; Vol. 14, pp. 440. Date of Electronic Publication: 2023 Dec 22 (Print Publication: 2023).
DOI:	10.25259/SNI_744_2023
Abstrakt:	Background: The COVID-19 pandemic in 2020 profoundly impacted healthcare worldwide, and Peru was particularly affected, experiencing the highest COVID-19 case fatality rate globally. Methods: We conducted a retrospective comparative study of patients presenting with aneurysmal subarachnoid hemorrhage (SAH) at a public Peruvian national referral center specializing in cerebrovascular diseases. Two study periods were considered, one during the first wave of the COVID-19 pandemic and a second identical period in 2019. Variables included patient demographics, comorbidities, COVID-19 infection status, clinical presentation, treatment approaches, and hospital outcomes. Results: We analyzed 114 patients with aneurysmal SAH, 65 (57.0%) treated in 2019 and 49 (43.0%) in 2020. The mean time from emergency admission to the day of definitive treatment during 2019 and 2020 was 2.72 and 1.93 days, respectively. Likewise, the mean time from symptom onset to the date of definitive treatment was 6.71 and 7.70 days, respectively. We identified significant associations between complications such as sepsis, respiratory failure, acute kidney failure, and hospital mortality. The proportion of fatalities was significantly higher in 2020 compared to 2019 (36.7% vs. 15.4%, respectively). Interestingly, there was no statistically significant association between COVID-19 infection status and mortality during the 2020 period. Conclusion: Patients with aneurysmal SAH treated during the pandemic had a higher proportion of sepsis, respiratory failure, acute kidney failure, and mortality compared to the pre-pandemic period. Reallocating healthcare resources to prioritize COVID-19 patients may have inadvertently neglected or delayed care for patients with other emergency conditions, such as aneurysmal SAH. This highlights the importance of maintaining adequate care for non-infectious emergencies during a pandemic. Competing Interests: There are no conflicts of interest. (Copyright: © 2023 Surgical Neurology International.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu